SCHEMBL5369902

SCHEMBL5369902

COC(=O)c1cc(S(=O)(=O)Nc2ccc(OCc3ccc(F)c(F)c3)cc2)ccc1C

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.55
POLB P06746 2/20 0.53
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
PKM P14618 1/20 0.50
MAOA P21397 1/20 0.47
MAOB P27338 1/20 0.47
KDM4E B2RXH2 1/20 0.47
MAPK1 P28482 1/20 0.47
AR P10275 3/20 0.47
PABPC1 P11940 1/20 0.46
TDP1 Q9NUW8 1/20 0.45
ALDH1A1 P00352 1/20 0.45
MGAT2 Q10469 1/20 0.45
PGR P06401 1/20 0.44
HTT P42858 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
TP53 P04637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5373270 0.91 POLB (0.63) SMN1; SMN2POLBMEN1KMT2APKM
SCHEMBL5380794 0.89 SMN1; SMN2 (0.58) SMN1; SMN2POLBMEN1KMT2APKM
SCHEMBL4906442 0.87 MAPT (0.50) SMN1; SMN2MEN1KMT2AMAOAMAOB
SCHEMBL5378800 0.87 SMN1; SMN2 (0.60) SMN1; SMN2POLBMEN1KMT2APKM
SCHEMBL5376600 0.86 MMP2 (0.55) SMN1; SMN2POLBMEN1KMT2APKM
SCHEMBL5376792 0.85 SMN1; SMN2 (0.59) SMN1; SMN2POLBMEN1KMT2APKM
SCHEMBL5380795 0.83 POLB (0.47) SMN1; SMN2POLBMEN1KMT2AKDM4E
SCHEMBL5373265 0.83 KMT2A (0.64) SMN1; SMN2POLBMEN1KMT2APKM
SCHEMBL5376620 0.83 SMN1; SMN2 (0.53) SMN1; SMN2POLBMEN1KMT2APKM
SCHEMBL4906453 0.81 LMNA (0.48) SMN1; SMN2MAOAMAOBKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PFIZER INC 2006-11-16 US disclosed
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD SMN1; SMN2 3404/4885POLB 1807/4885MEN1 4855/4885
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARG, PPARA, PPARD SMN1; SMN2 3296/4885POLB 2006/4885MEN1 4861/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.